Sensemedic in Hong Kong

Sensemedic in Hong Kong

Evalan started delivering Sensemedic services in Hong Kong to lung cancer patients. These services are delivered as part of a trial project with 200 patients.

Sensemedic is Evalan’s “Real Time Medication Monitoring” system which supports medication adherence improvements. Each participating patient uses Sensemedic’s smart medication dispenser that collects medication intake information in real time. This enables Sensemedic to provide smart reminding functions to the patient, and to deliver detailed information about medication intake to designated healthcare professionals so they can guide and support patients from existing behaviour towards a better intake pattern.

For the project in Hong Kong, Sensemedic’s portal functionalities were expanded to include questionnaires, which are sent periodically to patients in accordance with the trial schedule.

This project will run for at least 2 years.

Sensemedic in Hong Kong

FDA Approval Sensemedic for US

FDA Approval Sensemedic for US

Evalan has received approval from the US Food and Drug Administration (FDA) to distribute and sell Sensemedic to the US market. Sensemedic has been available in Europe, Asia and Africa since 2007 and will now also be available in the US.

Support patients towards a better intake pattern

Sensemedic is smart medication reminding system that can improve medication adherence. It uses a proprietary medication dispenser with real-time communication technology. This dispenser monitors the intake behaviour of patients. The information that is collected by the dispenser makes it possible to remind patients to take their medication if they forget, and for healthcare professionals to guide and support patients from existing behaviour towards a better intake pattern.

Evalan helps pharmaceutical companies and research institutes

Evalan offers Sensemedic to healthcare institutions, pharmaceutical companies and research institutes. The FDA approval is an important step for Sensemedic as there is significant interest in the US for systems that help improve medication adherence. This interest is also driven by a desire to introduce more self-management in patient care, and by concerns about rising healthcare costs.

FDA Approval Sensemedic for US